Scientist Jarrett Bilton, PhD recently travelled to the 25th North American ISSX conference in Boston. In collaboration with researchers at Genentech, RepliGut® Planar Jejunum was evaluated for gene expression patterns in response to prototypical metabolic inducers Rifampin, CITCO, 3-MC, and Calcitriol. The poster shows the suitability of RepliGut® Planar Jejunum for studying the contribution of intestinal epithelial cells to drug-drug interactions.